The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5,7-dimethyl-9H-[1,2,4]triazino[6,5-b]indol-3-ylthio)-N-(thiophen-2-ylmethyl)acetamide ID: ALA521390
PubChem CID: 20967209
Max Phase: Preclinical
Molecular Formula: C18H17N5OS2
Molecular Weight: 383.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)c2c(c1)[nH]c1nnc(SCC(=O)NCc3cccs3)nc12
Standard InChI: InChI=1S/C18H17N5OS2/c1-10-6-11(2)15-13(7-10)20-17-16(15)21-18(23-22-17)26-9-14(24)19-8-12-4-3-5-25-12/h3-7H,8-9H2,1-2H3,(H,19,24)(H,20,22)
Standard InChI Key: OSJRUUBDPBOLBK-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-4.2458 -7.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2458 -8.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5338 -8.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5338 -7.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8218 -7.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8172 -8.3218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0303 -8.5728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0376 -7.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5473 -7.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7332 -7.8056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4029 -7.0513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8932 -6.3891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7138 -6.4811 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5338 -6.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9597 -8.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5637 -5.6328 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2561 -5.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5856 -4.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4054 -4.6909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0954 -4.1201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8956 -5.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7154 -5.2617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2728 -5.8655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0238 -5.5240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9310 -4.7041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1227 -4.5392 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10 11 2 0
11 12 1 0
12 13 2 0
1 4 2 0
4 14 1 0
6 7 1 0
2 15 1 0
7 9 1 0
12 16 1 0
8 5 1 0
16 17 1 0
8 9 2 0
17 18 1 0
2 3 2 0
18 19 1 0
3 6 1 0
18 20 2 0
5 4 1 0
19 21 1 0
5 6 2 0
21 22 1 0
22 23 2 0
1 2 1 0
8 13 1 0
9 10 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.50Molecular Weight (Monoisotopic): 383.0875AlogP: 3.59#Rotatable Bonds: 5Polar Surface Area: 83.56Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.75CX Basic pKa: 0.09CX LogP: 3.50CX LogD: 3.50Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -2.25
References 1. Yu WM, Guvench O, Mackerell AD, Qu CK.. (2008) Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay., 51 (23): [PMID:19007293 ] [10.1021/jm800229d ] 2. Shen D, Chen W, Zhu J, Wu G, Shen R, Xi M, Sun H.. (2020) Therapeutic potential of targeting SHP2 in human developmental disorders and cancers., 190 [PMID:32061959 ] [10.1016/j.ejmech.2020.112117 ]